Search for: "Biotechnology Industry Organization" Results 641 - 660 of 812
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Aug 2009, 8:58 am
While not invited to the party in person, the Biotechnology... [read post]
17 Aug 2009, 9:59 pm
By Donald Zuhn -- Last week, the Biotechnology Industry Organization (BIO) and Thomson Reuters released the results of an investor perception study conducted earlier this year that correctly forecast a rebound for the biotech industry. [read post]
16 Aug 2009, 9:59 pm
By Donald Zuhn -- Last week, CNBC anchor Joe Kernen challenged Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood over the wisdom of implementing a follow-on biologics (FOB) regulatory pathway that provides innovator biologics manufacturers with 12 years of exclusivity. [read post]
16 Aug 2009, 1:59 am
"It's like fiddling while Rome is burning," said Nothhaft, a prominent advocate for reform.Hans Sauer, associate general counsel at the Biotechnology Industry Organization, a trade group for pharmaceutical and environmental companies, shares the sentiment. [read post]
14 Aug 2009, 9:58 pm
The Biotechnology Industry Organization (BIO) will be holding its Intellectual Property Counsels' Committee (IPCC) Fall Conference & Meeting on October 26-28, 2009 in Washington, DC. [read post]
13 Aug 2009, 9:59 pm
Noonan -- The Biotechnology Industry Organization (BIO) filed an amicus brief with the Supreme Court last week in Bilski v. [read post]
4 Aug 2009, 9:59 pm
Hans Sauer, the Associate General Counsel for Intellectual Property for the Biotechnology Industry Organization (BIO); Joshua Sarnoff, Professor of the Practice of Law at American University's Washington College of Law; and Shobita Parthasarathy, Co-Director of the Science, Technology and Public Policy Program at the Ford School of Public Policy at the University of Michigan discussed the topic on WAMU, Washington, DC's leading public radio station (see… [read post]
3 Aug 2009, 10:01 am
Biotechnology Industry Organization President and CEO Jim Greenwood issued a press release saying: The strong bipartisan support in the Energy and Commerce Committee for a fair and balanced pathway for the approval of biosimilars is a decisive win for the patients of today and tomorrow. [read post]
27 Jul 2009, 3:06 pm
On a July 20 conference call on development of algae for fuels and chemicals, sponsored by the Biotechnology Industry Organization, leading experts in the field discussed challenges and opportunities for commercializing the technology and how algae-based fuels can play a key role in climate change legislation pending in Congress because of its reliance on CO2. [read post]
23 Jul 2009, 7:00 am
We are providing an economic boost by invigorating New York's biotechnology industry. [read post]
16 Jul 2009, 9:59 pm
Anna Eshoo (D-CA), economist Alex Brill, Momenta Pharmaceuticals General Counsel Bruce Leicher, and representatives from the National Venture Capital Association (NVCA), Biotechnology Industry Organization (BIO), U.S. [read post]
8 Jul 2009, 9:55 pm
By Donald Zuhn -- During a Wednesday afternoon teleconference, Jim Greenwood, the President and CEO of the Biotechnology Industry Organization (BIO), discussed a recent "flurry of activity" surrounding follow-on biologics legislation currently being debated in Congress. [read post]
2 Jul 2009, 8:00 am
Simply put, the same corporate governance regime is not necessarily optimal for a struggling Midwest industrial manufacturer, a small-cap biotechnology company in Silicon Valley, and a dominant financial services firm in New York. [read post]
26 Jun 2009, 7:26 pm
The Pharmaceutical Research and Manufacturers of America and the Biotechnology Industry Organization said that if the Supreme Court does not take up the case, False Claims lawsuits would “skyrocket. [read post]
26 Jun 2009, 2:29 pm
BIO President and CEO Jim Greenwood issued a statement regarding biosimilars: The Biotechnology Industry Organization continues to support strongly the development of a pathway for the review and approval of biosimilars. [read post]
23 Jun 2009, 1:49 pm
"Responding earlier to the introduction of Waxman's Bill, the Biotechnology Industry Organization's President and CEO Jim Greenwood argued that the Bill "does not strike the necessary balance for patients or the economy" as it would de-incentivise investment into research and new drugs by enabling competition from FOBs. [read post]
22 Jun 2009, 3:37 am
As a result of industry mergers and an expected health-care overhaul by the Obama administration, lawyers with experience in the industries of health care, pharmaceuticals, biotechnology and medical devices are hot properties. [read post]
19 Jun 2009, 12:30 pm
” and then they ask the experts to explain the what, why and how of the biotechnology industry, and what it means for Kentucky. [read post]
19 Jun 2009, 7:16 am
Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood gave Kappos a thumbs up: We believe Mr. [read post]
18 Jun 2009, 5:19 pm
Brief amicus curiae of Academic Research Scientists Brief amicus curiae of Pharmaceutical Research and Manufacturers of America and Biotechnology Industry Organization Brief amicus curiae of Council of American Survey Research Organizations, Inc. and Pharmaceutical Marketing Research Group, Inc. [read post]